Dar Zavain — SEC insider filings

SEC reporting owner CIK 1852075. 24 insider filings on record with FilingPulse; latest filed 2026-10-02.

Transaction summary — filings shown

Covers all 24 filings on record, filed 2021-12-09 to 2026-10-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RECURSION PHARMACEUTICALS, INC. (RXRX)Director24—1 leg · 20,141 sh · $181,26927

Insider filings — Dar Zavain

FiledFormIssuerReported transactionsSource
2026-10-024RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 4,607 @ $0EDGAR
2026-07-024RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 5,109 @ $0EDGAR
2026-06-224RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 88,424 @ $0EDGAR
2026-04-024RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 4,902 @ $0EDGAR
2026-01-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 3,571 @ $0EDGAR
2025-10-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 2,941 @ $0EDGAR
2025-07-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 2,924 @ $0EDGAR
2025-06-234RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 22,016 @ $0 · Grant/award (A): 44,031 (derivative) @ $0EDGAR
2025-04-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 2,745 @ $0EDGAR
2025-01-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,907 @ $0EDGAR
2024-10-044RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 2,229 @ $0EDGAR
2024-07-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,843 @ $0EDGAR
2024-06-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0EDGAR
2024-04-034RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,467 @ $0EDGAR
2024-01-044RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,393 @ $0EDGAR
2023-12-184RECURSION PHARMACEUTICALS, INC. (RXRX)Sale (S): 20,141 @ $9EDGAR
2023-10-044RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,920 @ $0EDGAR
2023-07-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,863 @ $0EDGAR
2023-06-214RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 12,612 @ $0 · Grant/award (A): 25,224 (derivative) @ $0EDGAR
2023-04-284/ARECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,996 @ $0EDGAR
2023-04-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 1,996 @ $0EDGAR
2022-07-124RECURSION PHARMACEUTICALS, INC. (RXRX)Other (J): 2,420 @ $0EDGAR
2022-06-164RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 18,145 @ $0 · Grant/award (A): 36,290 (derivative) @ $0EDGAR
2021-12-094RECURSION PHARMACEUTICALS, INC. (RXRX)Other (J): 3,599 @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2021-12-08 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1852075 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs